Thierry Fumeaux
Direttore Tecnico/Scientifico/R&S presso Kinarus AG
Profilo
Thierry Fumeaux is currently the Chief Medical Officer at Kinarus AG and Kinarus Therapeutics Holding AG.
He holds a Master's degree in Business Administration from the International Institute for Management Development.
Posizioni attive di Thierry Fumeaux
| Società | Posizione | Inizio |
|---|---|---|
Kinarus AG
 Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Direttore Tecnico/Scientifico/R&S | 21/01/2021 |
Precedenti posizioni note di Thierry Fumeaux
| Società | Posizione | Fine |
|---|---|---|
| KINARUS THERAPEUTICS HOLDING AG | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Thierry Fumeaux
| International Institute for Management Development | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |
Kinarus Therapeutics Holding AG
 Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Thierry Fumeaux
